Key result
Coronary artery disease is frequently underdiagnosed in dialysis patients, and bypass grafting is the preferred therapeutic option over PTCA due to high reocclusion rates.
Bypass grafting is preferred over PTCA in dialysis patients with coronary artery disease due to high reocclusion rates, alongside careful medical and anemia management.
Supports cautious CAD evaluation and bypass preference in dialysis; leaves open optimal strategies for prospective trials.
Coronary artery disease is a frequent condition in dialysis patients and-probably due to the atypical symptomatology-is frequently underdiagnosed. Noninvasive tests are of limited value in establishing diagnosis, whereby arteriography is frequently necessary. Secondary prophylaxis is the same as in nondialysis patients. Due to a high reocclusion rate following PTCA bypass grafting is the preferred therapeutical option. When medical therapy is indicated, hemodialysis therapy should be adapted to coexistent coronary artery disease by avoiding dialysis hypotension and overhydration. In coronary patients renal anemia worsens coronary perfusions and should be treated targeting at least a hematocrit of 35%.
No takes yet. Share an insight, caveat, or question.
V. Wizemann (2008) conducted a review in Coronary artery disease in dialysis patients. Coronary artery disease is frequently underdiagnosed in dialysis patients, and bypass grafting is the preferred therapeutic option over PTCA due to high reocclusion rates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: